celecoxib
Term · Oncology and biomedicine · MLC-T-ONC-001550
A drug that reduces pain. Celecoxib belongs to the family of drugs called nonsteroidal anti-inflammatory agents. It is being studied in the prevention of cancer.
A nonsteroidal anti-inflammatory drug (NSAID) with a diaryl-substituted pyrazole structure. Celecoxib selectively inhibits cyclo-oxygenase-2 activity (COX-2); COX-2 inhibition may result in apoptosis and a reduction in tumor angiogenesis and metastasis.
| Identifier | MLC-T-ONC-001550 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | SC-58635 |
| Synonyms | YM 177 |
| References | NCI Dictionary of Cancer Terms; National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-001550",
"term": "celecoxib",
"field": "Oncology and biomedicine",
"definitions": [
"A drug that reduces pain. Celecoxib belongs to the family of drugs called nonsteroidal anti-inflammatory agents. It is being studied in the prevention of cancer.",
"A nonsteroidal anti-inflammatory drug (NSAID) with a diaryl-substituted pyrazole structure. Celecoxib selectively inhibits cyclo-oxygenase-2 activity (COX-2); COX-2 inhibition may result in apoptosis and a reduction in tumor angiogenesis and metastasis."
],
"abbreviation": "SC-58635",
"synonyms": [
"YM 177"
],
"references": [
"NCI Dictionary of Cancer Terms",
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/celecoxib/"
}
Record 4,545 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.